Cboe UK GBp

Indivior PLC (INDVL.XC)

840.00

+17.50

+(2.13%)

At close: May 16 at 4:29:51 PM GMT+1

Indivior to Participate in Upcoming Investor Events

Indivior PLC (NASDAQ/LSE: INDV) today announced that it will participate in the following investor events:

PR Newswire 4 days ago

INDV
New Study Highlights Monthly SUBLOCADE® as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy

Indivior PLC (Nasdaq/LSE: INDV) today announced the publication of a study "Monthly Buprenorphine Depot Injection (SUBLOCADE) for Opioid Use Disorder During Pregnancy" in the American Journal on Addictions, evaluating the use of SUBLOCADE for the treatment of opioid use disorder (OUD) during pregnancy and postpartum. Three sources of data evaluated in this retrospective study illustrated that the use of monthly SUBLOCADE during pregnancy demonstrated no increased risk and is consistent with the

PR Newswire 16 days ago

INDV
Indivior First Quarter 2025 Earnings: Beats Expectations

Indivior ( LON:INDV ) First Quarter 2025 Results Key Financial Results Revenue: US$266.0m (down 6.3% from 1Q 2024). Net...

Simply Wall St. 18 days ago

INDV
Indivior PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Indivior PLC ( LON:INDV ) investors will be delighted, with the company turning in some strong numbers with its latest...

Simply Wall St. 19 days ago

INDV
Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates

Indivior (INDV) delivered earnings and revenue surprises of 86.36% and 11.51%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 23 days ago

INDV
Indivior Announces Q1 2025 Financial Results

Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending March 31, 2025. The earnings release, investor presentation and webcast are available at www.indivior.com.

PR Newswire 23 days ago

INDV
Is Indivior PLC (INDV) the Best Stock to Buy According to Howard Marks’ Oaktree Capital Management?

We recently published a list of 10 Best Stocks to Buy According to Howard Marks’ Oaktree Capital Management. In this article, we are going to take a look at where Indivior PLC (NASDAQ:INDV) stands against other best stocks to buy according to Howard Marks’ Oaktree Capital Management. Howard Marks is an American billionaire and the […]

Insider Monkey last month

INDV

^GSPC
Indivior Insiders Placed Bullish Bets Worth US$1.42m

Over the last year, a good number of insiders have significantly increased their holdings in Indivior PLC ( LON:INDV...

Simply Wall St. last month

INDV
Indivior Announces Further Changes to Board of Directors

Indivior PLC (NASDAQ / LSE: INDV) ("Indivior" or the "Company") today announced that, further to the announcement on December 17, 2024 of certain Director arrangements agreed with Oaktree Capital Management L.P. ("Oaktree"), the announcement on January 28, 2025 of the appointment of Dr. David Wheadon as Chair of the Company, the announcement on February 3, 2025 of the appointment of Daniel Ninivaggi as an Independent Non-Executive Director of the Company, and the announcement on February 27, 202

PR Newswire 2 months ago

INDV
Is Indivior PLC (INDV) the Best Small Cap Pharma Stock to Buy Now?

We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look at where Indivior PLC (NASDAQ:INDV) stands against the other small cap pharma stocks. Impact of US Tariffs and Obesity Drug Performance on the Pharmaceutical Industry Emily Field, Head of European […]

Insider Monkey 2 months ago

INDV

LLY
Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer

Indivior PLC (Nasdaq/LSE: INDV) has appointed Joe Ciaffoni, currently an Independent Non-Executive Director of the Company, as Chief Executive Officer. The terms of his appointment are subject to, and effective upon, the approval by shareholders of a new remuneration policy at the Company's AGM in May 2025.

PR Newswire 2 months ago

INDV
Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection

Indivior PLC (Nasdaq/LSE: INDV), a global leader in addiction treatment, today announced that the U.S. Food and Drug Administration (FDA) has approved label changes for SUBLOCADE® including a rapid initiation protocol and alternative injection sites, marking a significant advancement in the treatment of moderate to severe opioid use disorder (OUD).

PR Newswire 2 months ago

INDV
Indivior Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Indivior ( LON:INDV ) Full Year 2024 Results Key Financial Results Revenue: US$1.19b (up 8.7% from FY 2023). Net loss...

Simply Wall St. 2 months ago

INDV
Indivior PLC (INDV) (Q4 2024) Earnings Call Highlights: Strong SUBLOCADE Growth and Strategic ...

Indivior PLC (INDV) reports a 20% increase in SUBLOCADE net revenue for 2024, while implementing significant cost-saving measures to enhance financial flexibility.

GuruFocus.com 2 months ago

INDV
European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat

Indivior Plc (NASDAQ:INDV) stock plunged following the company’s fiscal year 2025 guidance that fell short of Street expectations. Addiction and mental illnesses-focused Indivior reported fourth-quarter sales of $298 million, up 2% year over year, beating the consensus of $259.3 million. The London-based healthcare firm reported adjusted EPS of 32 cents, down from 43 a year ago, beating the consensus of 21 cents. In the fourth quarter, adjusted operating profit remained unchanged at $66 million,

Benzinga 2 months ago

INDV
Indivior PLC (INDV) Q4 Earnings Meet Estimates

Indivior (INDV) delivered earnings and revenue surprises of 0% and 13.98%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

INDV
Indivior Announces FY and Q4 2024 Financial Results

Indivior PLC (Nasdaq/LSE: INDV) today announced its financial results for the period ending December 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com.

PR Newswire 2 months ago

INDV
Stocks to watch this week: Alibaba, Walmart, HSBC, Rio Tinto and Lloyds

Earnings preview of key companies reporting this week and what to look out for.

Yahoo Finance UK 2 months ago

RIO

RTNTF

RTPPF
Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for

Indivior (INDV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 3 months ago

INDV

KPTI
Here’s Summers Value Partners’ Investment Thesis for Indivior (INDV)

Summers Value Partners, an investment management company, released its fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The Summers Value Fund LP returned a net1 return of 27.4% in 2024 outperforming 11.3% return for its primary benchmark, the Russell 2000 Index ETF (IWM). The fund also outperformed its secondary […]

Insider Monkey 3 months ago

INDV

^RUT

Performance Overview

Return	INDVL.XC	FTSE 100 (^FTSE)
YTD	-18.21%	+6.26%
1-Year	-37.64%	+2.91%
3-Year	-43.85%	+16.34%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Indivior PLC (INDVL.XC)

Indivior to Participate in Upcoming Investor Events

New Study Highlights Monthly SUBLOCADE® as a Potential Treatment Option for Opioid Use Disorder During and After Pregnancy

Indivior First Quarter 2025 Earnings: Beats Expectations

Indivior PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates

Indivior Announces Q1 2025 Financial Results

Is Indivior PLC (INDV) the Best Stock to Buy According to Howard Marks’ Oaktree Capital Management?

Indivior Insiders Placed Bullish Bets Worth US$1.42m

Indivior Announces Further Changes to Board of Directors

Is Indivior PLC (INDV) the Best Small Cap Pharma Stock to Buy Now?

Indivior Announces Joseph Ciaffoni Appointed Chief Executive Officer

Indivior Announces FDA Approval of Label Changes for SUBLOCADE® (buprenorphine extended-release) Injection

Indivior Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Indivior PLC (INDV) (Q4 2024) Earnings Call Highlights: Strong SUBLOCADE Growth and Strategic ...

European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat

Indivior PLC (INDV) Q4 Earnings Meet Estimates

Indivior Announces FY and Q4 2024 Financial Results

Stocks to watch this week: Alibaba, Walmart, HSBC, Rio Tinto and Lloyds

Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for

Here’s Summers Value Partners’ Investment Thesis for Indivior (INDV)

Performance Overview